BCM
SNV

Bayesian Capital Management’s Synovus SNV Stock Holding History

Bayesian Capital Management’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,067
Closed -$759K – 977
2024
Q3 		$759K Buy
+17,067
New +$746K 0.09% 285
2023
Q2 		– Sell
-6,953
Closed -$214K – 1039
2023
Q1 		$214K Buy
+6,953
New +$265K 0.03% 596
2021
Q2 		– Sell
-8,393
Closed -$384K – 626
2021
Q1 		$384K Buy
+8,393
New +$352K 0.09% 291
2019
Q4 		– Sell
-15,100
Closed -$540K – 740
2019
Q3 		$540K Buy
+15,100
New +$542K 0.1% 262

Other funds holding SNV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bayesian Capital Management's SNV Position: Q4 2024 in Review

Bayesian Capital Management sold out of Synovus (SNV) in Q4 2024, closing a stake of 17,067 shares — an estimated $759K sold.

Bayesian Capital Management first reported a position in SNV in Q3 2019 and held it in 4 quarters. The position peaked at $759K in Q3 2024. 458 funds tracked by Wall St. Rank hold SNV as of Q4 2024.

  • Bayesian Capital Management reported no remaining Synovus position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 17,067 Synovus shares in Q4 2024, an estimated $759K.
  • Bayesian Capital Management first reported a position in Synovus in Q3 2019 and held it in 4 quarters.
  • Bayesian Capital Management's Synovus position peaked at $759K in Q3 2024.
  • 458 funds tracked by Wall St. Rank held Synovus as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.